Economic evaluation of adjuvant trastuzumab emtansine in patients with her2-positive early breast cancer and residual invasive disease after neoadjuvant taxane and trastuzumab–based treatment in Canada

T. Younis, A. Lee, M. E. Coombes, N. Bouganim, D. Becker, C. Revil, G. S. Jhuti

Résultat de recherche: Articleexamen par les pairs

9 Citations (Scopus)

Empreinte numérique

Plonger dans les sujets de recherche 'Economic evaluation of adjuvant trastuzumab emtansine in patients with her2-positive early breast cancer and residual invasive disease after neoadjuvant taxane and trastuzumab–based treatment in Canada'. Ensemble, ils forment une empreinte numérique unique.

Medicine & Life Sciences